New Study Identifies Fat-Storing Gene That May Increase Anorexia Nervosa Risk
Researchers found rare potentially damaging variants in the PLIN4 gene among some patients with anorexia, pointing toward a possible metabolic component of the disorder.
A new study reports that patients with anorexia nervosa were nearly four times as likely as a reference population to carry rare potentially damaging PLIN4 gene variants, although researchers stress that the finding needs replication.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Anorexia nervosa has traditionally been studied primarily through psychological, behavioral and brain-based mechanisms. New research is adding another dimension by investigating how the body's ability to store and use energy may influence susceptibility to the eating disorder.
Researchers identified rare potentially damaging variants in the PLIN4 gene, which is primarily active in fat and muscle tissue. Among a specialized group of 154 patients with anorexia, approximately 11% carried rare variants predicted to damage the gene, compared with around 3% in a healthy reference population.
PLIN4 is involved in the regulation of fat storage, raising the possibility that altered metabolism could contribute to anorexia in some individuals.
The researchers emphasize that this does not mean that PLIN4 causes anorexia or that genetic testing can currently predict who will develop the disorder. The study involved a specialized patient group, and the findings must be replicated in larger independent populations.
Nevertheless, the research is important because it supports a broader understanding of anorexia as a serious biological and psychiatric illness rather than simply a behavioral choice.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
